GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,822,000 | -0.2% | 41,819 | +1.0% | 0.39% | +2.1% |
| Q4 2021 | $1,825,000 | +17.1% | 41,393 | +1.5% | 0.39% | +10.6% |
| Q3 2021 | $1,558,000 | +1.4% | 40,774 | +5.7% | 0.35% | +2.3% |
| Q2 2021 | $1,536,000 | +14.0% | 38,574 | +2.2% | 0.34% | +8.6% |
| Q1 2021 | $1,347,000 | -1.5% | 37,738 | +1.5% | 0.31% | -7.9% |
| Q4 2020 | $1,368,000 | +12.6% | 37,163 | +15.2% | 0.34% | -1.7% |
| Q3 2020 | $1,215,000 | +3.0% | 32,270 | +11.5% | 0.35% | -3.6% |
| Q2 2020 | $1,180,000 | +7.7% | 28,935 | 0.0% | 0.36% | -12.2% |
| Q1 2020 | $1,096,000 | -19.4% | 28,935 | 0.0% | 0.41% | +6.5% |
| Q4 2019 | $1,360,000 | +10.1% | 28,935 | 0.0% | 0.38% | +8.8% |
| Q3 2019 | $1,235,000 | +23.7% | 28,935 | +16.0% | 0.35% | +18.0% |
| Q2 2019 | $998,000 | -4.2% | 24,940 | 0.0% | 0.30% | -7.7% |
| Q1 2019 | $1,042,000 | +9.3% | 24,940 | 0.0% | 0.32% | -2.7% |
| Q4 2018 | $953,000 | -3.7% | 24,940 | +1.2% | 0.33% | +9.9% |
| Q3 2018 | $990,000 | +0.6% | 24,640 | +0.9% | 0.30% | -6.5% |
| Q2 2018 | $984,000 | +11.7% | 24,415 | +8.3% | 0.32% | +66.7% |
| Q1 2018 | $881,000 | -1.5% | 22,550 | -10.5% | 0.20% | +2.1% |
| Q4 2017 | $894,000 | +23.7% | 25,200 | +41.5% | 0.19% | +23.2% |
| Q3 2017 | $723,000 | -1.9% | 17,810 | +4.2% | 0.16% | +15.7% |
| Q2 2017 | $737,000 | +2.2% | 17,095 | 0.0% | 0.13% | +0.8% |
| Q1 2017 | $721,000 | +72.9% | 17,095 | +57.8% | 0.13% | +68.4% |
| Q4 2016 | $417,000 | -10.7% | 10,830 | 0.0% | 0.08% | -11.2% |
| Q3 2016 | $467,000 | -0.4% | 10,830 | 0.0% | 0.09% | +4.7% |
| Q2 2016 | $469,000 | +40.8% | 10,830 | +32.1% | 0.08% | +37.1% |
| Q1 2016 | $333,000 | +0.6% | 8,200 | 0.0% | 0.06% | +1.6% |
| Q4 2015 | $331,000 | -2.1% | 8,200 | +1.0% | 0.06% | -1.6% |
| Q2 2015 | $338,000 | -1.5% | 8,115 | +9.2% | 0.06% | +1.6% |
| Q1 2015 | $343,000 | +7.9% | 7,430 | 0.0% | 0.06% | +8.9% |
| Q4 2014 | $318,000 | -7.0% | 7,430 | 0.0% | 0.06% | -5.1% |
| Q3 2014 | $342,000 | -13.9% | 7,430 | 0.0% | 0.06% | +5.4% |
| Q2 2014 | $397,000 | +16.8% | 7,430 | +16.8% | 0.06% | +30.2% |
| Q1 2014 | $340,000 | 0.0% | 6,360 | 0.0% | 0.04% | -2.3% |
| Q4 2013 | $340,000 | +4.0% | 6,360 | -2.4% | 0.04% | -2.2% |
| Q3 2013 | $327,000 | – | 6,515 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |